| Product Name | MF | CAS | Details |
|---|
| Lomefloxacin hydrochloride | C17H20ClF2N3O3 | 98079-52-8 | Details |
| 3-(2-Methylpropyl)-1H-indazole-5-carboxylic acid | C12H14N2O2 | 1883425-90-8 | Details |
| 2-Bromo-1-(4-methyloxan-4-yl)ethan-1-one | C8H13BrO2 | 1523412-39-6 | Details |
| 2,10-diaza-13-chloro-5,5,9-trimethyltricyclo[9.4.0.0<,3,8>,]pentadeca-1(11),3(8),12,14-tetraen-7-one | C16H19ClN2O | 946387-35-5 | Details |
| Bis(4-methylpentyl)phthalate | C20H30O4 | 259139-51-0 | Details |
| Methyl 2-bromo-4-chloronicotinate | C7H5BrClNO2 | 1804384-19-7 | Details |
| 2-Cyclopropylpyrimidine-4-carboxylic acid | C8H8N2O2 | 1211533-70-8 | Details |
| Magnesium iodite | I2Mg | 10377-58-9 | Details |
| RPL14 Blocking Peptide | Details |
| (3S,4R)-3-Amino-4-hydroxyoxolan-2-one hydrochloride | 21768-47-8 | Details |
| 1-(3-Chloro-4-fluorophenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid | C10H7ClFN3O2 | 1094411-42-3 | Details |
| 3-Bromo-6-methoxy-2-methylbenzoic acid | C9H9BrO3 | 220901-25-7 | Details |
| H-LVRPEVDVMCTAFHDNEETFLK-OH | Details |
| ethyl 4-(1H-indole-2-carbonyl)piperazine-1-carboxylate | C16H19N3O3 | 1024061-54-8 | Details |
| 8-Bromo-3’-deoxy-3’-fluorotoyocamycin | C12H11BrFN5O3 | 2095417-57-3 | Details |
| 2,2,2-Trifluoroethyl N-[4-(1H-1,2,4-triazol-1-yl)-2-(trifluoromethyl)phenyl]carbamate | C12H8F6N4O2 | 1235441-06-1 | Details |
| 3-Formylsalicylic acid hydrate | C8H8O5 | 1266615-78-4 | Details |
| 1-((tert-Butoxycarbonyl)amino)-2,2-dimethylcyclopentanecarboxylic acid | C13H23NO4 | 1536937-34-4 | Details |
| 5-chloro-1,2-oxazole-3-carboxylic acid | C4H2ClNO3 | 343566-57-4 | Details |
| BMS 345541 | C14Cl1H18N5 | 547757-23-3 | Details |
| N-Cyclohexylpiperidine-3-carboxamide hydrochloride | C12H23ClN2O | 937724-80-6 | Details |
| 2,5-Dimethylbenzaldehyde | C9H10O | 5779-94-2 | Details |
| Heveaflavone | C33H24O10 | 23132-13-0 | Details |
| 5-Ethenyl-2-oxo-3-pyrrolidinecarboxylic acid | C7H9NO3 | 71107-20-5 | Details |
| tert-Butyl 3-(trifluoroacetyl)azetidine-1-carboxylate | C10H14F3NO3 | 1628733-95-8 | Details |
| Z-Glu-Gly-OH | C15H18N2O7 | 1634-89-5 | Details |
| 3-(5-Cyclopropyl-1H-pyrazol-1-yl)-N'-hydroxypropanimidamide | C9H14N4O | 1006323-01-8 | Details |
| 2,?3,?3-Ttrimethyl-4-?isothiazolidinamine 1,?1-?dioxide | C6H14N2O2S | 2138271-48-2 | Details |
| Clindamycin-2-phosphate | C18H34ClN2O8PS | 24729-96-2 | Details |
| Sevoflurane | C4H3F7O | 28523-86-6 | Details |
| 2-Ethoxy-4-(3-hydroxybutyl)phenol | C12H18O3 | 1283091-06-4 | Details |
| Canine Factor VIII Antibody Pair | Details |
| N-Desmethyl N-ethyl olanzapine | C18H22N4S | 1355034-54-6 | Details |
| 6-Bromo-2-methoxypyrazolo[1,5-a]pyrimidine | C7H6BrN3O | 2092310-45-5 | Details |
| (4-Methyl-1H-imidazol-2-yl)methanamine dihydrochloride | C5H11Cl2N3 | 855250-27-0 | Details |
| 1H-Pyrrolo[2,3-b]pyridin-5-ylamine | C7H7N3 | 100960-07-4 | Details |
| 3-Fluoro-4-(hydroxymethyl)phenylboronic acid Pinacol Ester | C13H18BFO3 | 1082066-29-2 | Details |
| (2S,2'S)-2,2'-(1,3,8,10-Tetraoxoanthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-2,9(1H,3H,8H,10H)-diyl)dipropanoic acid | C30H18N2O8 | 925685-87-6 | Details |
| Biotin TAT (48-60) | Details |
| RBM8A protein (His tag) | Details |
| 3-Formyl-2-hydroxybenzoic acid | C8H6O4 | 610-04-8 | Details |
| ApoC-II antibody | Details |
| FCN2 Blocking Peptide | Details |
| ACTR10 Blocking Peptide | Details |
| tert-Butyl 3-amino-1,4-dihydro-5H-spiro[cyclobutane-1,6-pyrrolo[3,4-c]pyrazole]-5-carboxylate | C13H20N4O2 | 1246652-29-8 | Details |
| 1,3-Diethyl 2-(4-bromo-2-fluorobenzoyl)propanedioate | C14H14BrFO5 | 1432681-52-1 | Details |
| 2-Amino-2-(1,2-thiazol-5-yl)acetic acid | C5H6N2O2S | 32485-49-7 | Details |
| H-MTEYKLVVVGADGVG-OH | Details |
| Flavanone-d5 | C15H7D5O2 | 146196-91-0 | Details |
| FGF14 antibody | Details |
| (Z,Z)-3,6-nonadienal | C9H14O | 21944-83-2 | Details |
| 2-[[4-(2-Pyridylsulfamoyl)phenyl]azo]hydroxybenzene | C17H14N4O3S | 66364-70-3 | Details |
| tert-butyl 2,5-diazabicyclo[4.1.0]heptane-2-carboxylate | C10H18N2O2 | 1228675-18-0 | Details |
| 4,5-Dimethoxysalicylic Acid | C9H10O5 | 5722-93-0 | Details |
| Montelukast sulfone | C35H36ClNO5S | 1266620-74-9 | Details |
| 1-Chloro-7-nitroisoquinoline | C9H5ClN2O2 | 244219-94-1 | Details |
| rac-(1R,2S)-2-(2-Hydroxy-2-methylpropyl)cyclohexan-1-ol | C10H20O2 | 845507-62-2 | Details |
| 1-{4-[(3-Methylphenyl)methoxy]phenyl}ethan-1-one | C16H16O2 | 890092-06-5 | Details |
| 1-(4-bromophenyl)-1H-imidazole-4-carboxylic acid | C10H7BrN2O2 | 445302-27-2 | Details |
| H-KELYPLASLRSLFGS-OH | Details |
| 3-(Difluoromethoxy)-4-fluorobenzene-1-sulfonyl chloride | C7H4ClF3O3S | 1261738-71-9 | Details |
| 6-Chloroquinoline-4-carbaldehyde | C10H6ClNO | 482583-75-5 | Details |
| ((2-Fluorophenyl)sulfonyl)alanine | C9H10FNO4S | 1008050-74-5 | Details |
| N-(3-Amino-2-methylphenyl)-2-iodobenzamide | C14H13IN2O | 926255-88-1 | Details |
| MS4A7 antibody | Details |
| 2-[4-(1,3-Benzoxazol-2-yl)morpholin-2-yl]ethan-1-amine dihydrochloride | C13H18ClN3O2 | 1609403-31-7 | Details |
| Acequinocyl-hydroxy | C22H30O3 | 57960-31-3 | Details |
| N-(1-Cyano-1-methylethyl)benzamide | C11H12N2O | 54016-31-8 | Details |
| Na, K ATPase antibody | Details |
| 3-tert-Butyldimethylsilyloxybenzaldehyde | C13H20O2Si | 96013-95-5 | Details |
| Cytokeratin (pan) basic type 2 Ab | Details |
| N-[4-(Aminomethyl)phenyl]-4-butylcyclohexane-1-carboxamide | C18H28N2O | 1019400-32-8 | Details |
| 2-(3-(Trifluoromethoxy)phenyl)pyrrolidine hydrochloride | C11H13ClF3NO | 1189900-43-3 | Details |
| Methyl 5-amino-1-methyl-1H-pyrrole-2-carboxylate | C7H10N2O2 | 166182-90-7 | Details |
| tert-Butyl N-[3-oxo-2-(propan-2-yl)-2,3-dihydro-1H-pyrazol-4-yl]carbamate | C11H19N3O3 | 2044714-50-1 | Details |
| Urokinase protein | Details |
| FITC antibody | Details |
| Quinfamide | C16H13Cl2NO4 | 62265-68-3 | Details |
| 2-(2-Fluoro-3-methylphenyl)-2-hydroxyacetic acid | C9H9FO3 | 1214372-73-2 | Details |
| 3-Amino-3-(2-hydroxyethyl)-1λ?-thietane-1,1-dione hydrochloride | 2243514-92-1 | Details |
| 2-Isothiocyanato-2-methylpropanenitrile | C5H6N2S | 2167341-61-7 | Details |
| C19ORF47 antibody | Details |
| 1-Azido-3-methoxybenzene | 3866-16-8 | Details |
| 2-[(2,2,2-Trifluoroethyl)sulfanyl]ethan-1-amine hydrochloride | C4H9ClF3NS | 1427380-05-9 | Details |
| [4-Methyl-5-(trifluoromethyl)-4H-1,2,4-triazol-3-yl]methanol | C5H6F3N3O | 1549675-25-3 | Details |
| 1-[(3-{[(tert-Butoxy)carbonyl]amino}cyclobutyl)methyl]-1H-1,2,3-triazole-4-carboxylic acid | 2377033-34-4 | Details |
| Chk2 antibody (Thr68) | Details |
| tert-Butyl N-[(5-methylpiperidin-2-yl)methyl]carbamate | C12H24N2O2 | 1782752-94-6 | Details |
| 4-Amino-2-cyclohexylbutan-2-ol | C10H21NO | 1368332-19-7 | Details |
| 4-(tert-Butoxy)pyridin-3-amine | C9H14N2O | 1039893-67-8 | Details |
| 3-Amino-1-[4-(morpholine-4-sulfonyl)phenyl]thiourea | C11H16N4O3S2 | 554404-09-0 | Details |
| 4-(3,5-Dimethylpiperidin-1-yl)-3-nitrobenzoic acid | C14H18N2O4 | 309943-10-0 | Details |
| Riboflavin 5'-adenosine diphosphate disodium salt hydrate | C27H36N9NaO16P2 | 1891059-93-0 | Details |
| 3-Bromo-2-fluoropropan-1-ol | C3H6BrFO | 4161-56-2 | Details |
| H-ANLPQSFQVDTSK^-OH | Details |
| Fluhexafon | C12H17F3N2O3S | 1097630-26-6 | Details |
| 5-{[2-(tert-Butoxy)-2-oxoethoxy]methyl}-1,3-oxazole-4-carboxylic acid | C11H15NO6 | 1909319-49-8 | Details |
| Goat anti Cat IgG (H + L) (FITC) | Details |
| 4-(2-Ethoxyethoxy)-3-(propan-2-yl)benzene-1-thiol | C13H20O2S | 2138163-55-8 | Details |
| ABCC11 Blocking Peptide | Details |
| Product Total： Product Page： | ||||
| 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 | ||||